Related Experiment Video
Updated: Apr 23, 2026
09:01
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
6.2K
Some cross-talks between immune cells and epilepsy should not be forgotten
Hong Wang1, Sibo Liu, Zeyao Tang
1Dalian Municipal Central Hospital, No. 2 VIP Ward, Shahekou District, Dalian, 116000, Liaoning Province, China.
Summary
Investigating immune cells and epilepsy is crucial, as peripheral blood cells (PBCs) show significant alterations post-seizure. These immune cells, including leukocytes, influence epilepsy development through various mechanisms.
Area of Science:
- Neuroscience
- Immunology
- Epilepsy Research
Background:
- While direct brain infiltration by immune cells in epilepsy is debated, significant changes in peripheral blood cells (PBCs) post-seizure are evident.
- Specific transporters on immune cell membranes may influence neuronal excitability, linking peripheral immunity to brain function.
Purpose of the Study:
- To review evidence of peripheral blood cell alterations following seizures.
- To explore the specific roles of different immune cells in epilepsy pathogenesis.
Main Methods:
- Review of existing scientific literature on immune cells and epilepsy.
- Analysis of studies investigating peripheral blood cell changes after seizures.
- Examination of in vitro and in vivo evidence on immune cell functions in epilepsy models.
Main Results:
- Significant alterations in peripheral blood cells (PBCs) are observed immediately after seizure onset.
- Activated leukocytes adhere to the blood-brain barrier endothelium or infiltrate brain parenchyma in various epilepsy types.
- Distinct immune cell types exert differential effects on epilepsy development.
Conclusions:
- Peripheral blood cells (PBCs) are significantly impacted by seizures and warrant further investigation.
- Immune cells play multifaceted roles in the development and progression of epilepsy.
- Understanding these immune mechanisms offers potential therapeutic targets for epilepsy.
More Related Videos
Related Concept Videos
01:24Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
01:21EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
01:22Epilepsy ll: Types
24
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
24
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
01:26Encephalitis ll: Pathophysiology
13
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
13